A clinical trial to induce immunity and herd immunity against viruses including covid 19

Broad Spectrum Antiviral Prophylactic Unani Medicine to Induce Immunity and Herd immunity based on empirical evidence of unani system of medicine - BSAPUM

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/02/031547

Enrollment

Registered

2021-02-25

Start date

Unknown

Completion date

Unknown

Last updated

2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Aleo secondry metabolites like,Anthraqunones,Anthrones,Furan derivatives,Chromones,Cumatins,Flavonids,Phytosterols,Pyrans and pyrones,Organic and Inorganic constituents of Myrrah resin,

Eligibility

Inclusion criteria

Inclusion criteria: age group 9 to 80 years male and female with normal vitals and blood sugar

Exclusion criteria

Exclusion criteria: below 9 years, between mensuration in females and pregnancy in females

Design outcomes

Primary

Measure	Time frame
stress levels willbe reduced, frequency of cold effects will be reduced, tummy troubles (constipation and indigestion issues) will be reduced and feeling of triedness will be reducedTimepoint: 0 to 8 weeks	—

Secondary

Measure	Time frame
stress levels willbe reduced, frequency of cold effects will be reduced, tummy troubles (constipation and indigestion issues) will be reduced and feeling of triedness will be reducedTimepoint: 0 to 8 weeks	—

Countries

India

Contacts

Public ContactDr Syed Mujtaba Ali Hashmi

Dr. Hashmis Unani Medicine Observation & Research Foundation

dr_s_mujtabaali@yahoo.com9885828079

Outcome results